Literature DB >> 31951032

Presence of soluble and cell-surface B-cell maturation antigen in systemic light-chain amyloidosis and its modulation by gamma-secretase inhibition.

Amandeep Godara1,2, Ping Zhou2, Adin Kugelmass2, Xun Ma2, Benjamin Rosenthal2, Denis Toskic2, Teresa Fogaren2, Cindy Varga2, Raymond L Comenzo1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31951032     DOI： 10.1002/ajh.25734

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

Review 1.  Evaluating the Therapeutic Potential of Idecabtagene Vicleucel in the Treatment of Multiple Myeloma: Evidence to Date.

Authors:  Hashim Mann; Raymond L Comenzo
Journal:  Onco Targets Ther       Date:  2022-07-22       Impact factor: 4.345

2.  First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma.

Authors:  Aina Oliver-Caldes; Raquel Jiménez; Marta Español-Rego; Maria Teresa Cibeira; Valentín Ortiz-Maldonado; Luis F Quintana; Paola Castillo; Francesca Guijarro; Natalia Tovar; Mercedes Montoro; Daniel Benitez-Ribas; Alex Bataller; E Azucena González-Navarro; Joan Cid; Miquel Lozano; Lorena Perez-Amill; Beatriz Martin-Antonio; Mari-Pau Mena; David F Moreno; Luis Gerardo Rodríguez-Lobato; Josep Maria Campistol; Gonzalo Calvo; Joan Bladé; Laura Rosiñol; Manel Juan; Mariona Pascal; Alvaro Urbano-Ispizua; Carlos Fernández de Larrea
Journal:  J Immunother Cancer       Date:  2021-12       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.